Clinical trial

Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis

NCT03254589

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-10-01

PhasePHASE4

Study timeline

Study start (actual)2017-10-01Date precision: day

Registry last updated2025-02-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Stiffness, Aorticunresolved

Endothelial Dysfunctionunresolved

Cardiovascular Risk Factorunresolved

Interventions

MethotrexateDRUG · verified · RxNorm: methotrexate

SulfasalazineDRUG · verified · RxNorm: sulfasalazine

Other DMARDsDRUG

Sponsors & collaborators

Flinders Universitylead sponsor

University of South Australiacollaborator

medac GmbHcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03254589 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.